Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The association between IGF-I/IGFBP-3 and subclinical end points: epidemiology faces the limits.

The Journal of clinical endocrinology and metabolism - 1 Aug 2014

Müller Christiane, Wallaschofski Henri, Brabant Georg, Wahnschaffe Ulrich, Samietz Stefanie, Nauck Matthias, Friedrich Nele

Abstract excerpt

BACKGROUND: The variation in laboratory measurements represents a challenge in clinical practice and epidemiological research. The use of different analytical platforms might have led to different results, which were often discussed in the interpretation of conflicting results. We aim to study the impact of two different IGF-I and IGF binding protein 3 assays on published epidemiological studies. METHODS: We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Asymptomatic Diseases
Share to Cardiovascular Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Endpoint Determination

Share to Epidemiologic Research Design

Share to Immunoassay

Share to Insulin-Like Growth Factor Binding Protein 3

Share to Insulin-Like Growth Factor I

Share to Predictive Value of Tests

Source

Identifiers

PMID: 24823454
DOI: 10.1210/jc.2013-3746

Genes

IDS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The association between IGF-I/IGFBP-3 and subclinical end points: epidemiology faces the limits.PMID 24823454Read ↗

A genome-wide association study identifies novel loci associated with circulating IGF-I and IGFBP-3.Semantic proximity Read ↗

Genomewide meta‐analysis identifies loci associated with <scp>IGF</scp> ‐I and <scp>IGFBP</scp> ‐3 levels with impact on age‐related traitsSemantic proximity Read ↗

Relationship of proteins and subclinical cardiovascular traits in the population-based LIFE-Adult study.Semantic proximity Read ↗

Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study.Semantic proximity Read ↗

Oxidative stress-mediated (sex-specific) loss of protection against type-2 diabetes by macrophage migration inhibitory factor (MIF)-173G/C polymorphism.Semantic proximity Read ↗

Insulinlike Growth Factor-1 and Its Binding Protein-3 Polymorphisms Predict Circulating IGF-1 Level and Appendicular Skeletal Muscle Mass in Chinese Elderly.Semantic proximity Read ↗

The fibroblast growth factor-23 and Vitamin D emerge as nontraditional risk factors and may affect cardiovascular risk.Semantic proximity Read ↗

Predictors of variation in serum IGF1 and IGFBP3 levels in healthy African American and white men.Semantic proximity Read ↗

Unmasking residual cardiovascular risk: The paradoxical interaction between remnant cholesterol and calculated LDL-C in a high-risk cohortSemantic proximity Read ↗

A polymorphism at IGF1 locus is associated with carotid intima media thickness and endothelium-dependent vasodilatation.Semantic proximity Read ↗

Associations of insulin-like growth factor binding protein-3 gene polymorphisms with IGF-I activity and lipid parameters in adolescents.Semantic proximity Read ↗

The combined frequencies of the IL-6 G-174C and IGFBP3 A-202C polymorphisms among swimmers and runners.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.